Skip to main content
SpringerLink
Log in

Arrhythmias

Ruxolitinib is a CaMKII inhibitor that can be repurposed to prevent arrhythmias

  • Research Highlight
  • Published:

From Nature Reviews Cardiology

View current issue Sign up to alerts

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

Original article

  • Reyes Gaido, O. E. et al. An improved reporter identifies ruxolitinib as a potent and cardioprotective CaMKII inhibitor. Sci. Transl. Med. 15, eabq7839 (2023)

    Article  CAS  PubMed  Google Scholar 

Related article

Download references

Author information

Authors and Affiliations

  1. Nature Reviews Cardiology http://www.nature.com/nrcardio/

    Karina Huynh

Authors
  1. Karina Huynh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karina Huynh.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Huynh, K. Ruxolitinib is a CaMKII inhibitor that can be repurposed to prevent arrhythmias. Nat Rev Cardiol 20, 580 (2023). https://doi.org/10.1038/s41569-023-00910-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41569-023-00910-1

  • Springer Nature Limited

This article is cited by

Search

Navigation